Absorption, distribution, metabolism and excretion of ¹⁴C-labelled enantiomers of the calcium channel blocker benidipine after oral administration to rat

References

• ELTZE, M., BOER, R., SANDERS, K. H., Boss, H., ULRICH, W. R. and FLOCICERZI, D., 1990, Stereoselective inhibition of thromboxane-induced coronary vasocontraction by 1,4-dihydropyridine calcium channel antagonists. Chirality, 2, 233–240.
   PubMedGoogle Scholar
• ERICKSSON U. G., HOFFMANN, K.-J. SLMONSSON, R. and REGARDH, C. G., 1991a, Pharmacokinetics of the enantiomers of felodipine in the dog after oral and intravenous administration of a pseudoracemic mixture. Xenobiotica, 21, 75–84.
   PubMedGoogle Scholar
• ERIKSSON, U. G., LUNDAHL, J., BAARNHIELM, C. and REGARDH, C. G., 1991b, Stereoselective metabolism of felodipine in liver microsomes from rat, dog and human. Drug Metabolism and Disposition, 19, 889–894.
   PubMed Web of Science ®Google Scholar
• FISCHER, C SCHo NBERGER, F., MUCK, W., HEUCK, K. and EICHELBAUM, M., 1993, Simultaneous assessment of the intravenous and oral disposition of the enantiomers of racemic nimodipine by chiral stationary-phase high-performance liquid chromatography and gas chromatography/mass spectroscopy combined with a stable isotope technique. Journal of Pharmaceutical Science, 82, 244–250.
   PubMedGoogle Scholar
• GUENGERICH, F. P., PETERSON, L. A. and BOEKEK, R. H., 1988, Cytochrome P-450-catalyzed hy-droxylation and carboxylic acid ester cleavage of hantzsch pyridine ester. Journal of Biological Chemistry, 263, 8176–8183.
   PubMed Web of Science ®Google Scholar
• ISHII, A., NISHIDA, K., OKA, T. and NAKAMIZO, N., 1988, Receptor binding properties of the new calcium antagonist benidipine hydrochloride. Arzneimittel-Forschung/Drug Research 38, 1677–1680.
   PubMedGoogle Scholar
• KAJINO M., WADA, Y NAGAI, Y., NAGAOKA, A. and MEGURO, K., 1989, Synthesis and biological activities of optical isomers of 2-(4-diphenylmethy1-1-piperazinyBethyl methyl 1,4-dihydro-2,6-dimethy1-4-(3-nitropheny1)-3,5-pyridine-carboxylate (manidipine) dihydrochloride. Chemico-Pharmacological Bulletin, 37, 2225–2228.
   Google Scholar
• KARASAWA, A., Kuao, K., SHUTO, K., OKA, T. and NAKAMIZO, N., 1988a, Antihypertensive effects of the new calcium antagonist benidipine hydrochloride in rats. Arzneimittel-Forschung /Drug Research, 38, 1684–1690.
   PubMedGoogle Scholar
• KARASAWA, A., IKEDA, J., YAMADA, K., Kum), K., OKA, T. and NAKAMIZO, N., 1988b, Antihypertensive effects of the new calcium antagonist benidipine hydrochloride in conscious, renal-hypertensive dogs. Arzneimittel-Forschung/Drug Research, 38, 1695–1697.
   Google Scholar
• KARASAWA, A., Kuao, K., OKA, T. and NAKAMIZO, N., 1988c, Antihypertensive effects of intravenous administration of benidipine hydrochloride and some other calcium antagonists in conscious, spontaneously hypertensive rats. Arzneimittel-Forschung/Drug Research, 38, 1691–1694.
   PubMed Web of Science ®Google Scholar
• KARASAW A., Kum., K., SHUTO, K., OKA, T. and NAKAMIZO, N., 1988d, Antianginal effects of the new calcium antagonist benidipine hydrochloride in anesthetized rats and spontaneously hypertensive rats/electrocardiographic study. Arzneimittel-Forschung /Drug Research, 38, 1702–1707.
   Google Scholar
• KOBAYASHI, H., OHISHI, T., NISHIIE, H., KOBAYASHI, S., INOUE, A. and HIRATA, T., 1990a, Absorption, distribution and excretion of '4 C-Benidipine • HC1 in rats. Xenobiotk Metabolism and Disposition, 5, 71–86.
   Google Scholar
• KOBAYASHI, H., KOBAYASHI, S., INOUE, A. and HIRATA, T., 1991b, Pharmacokinetic study of benidipine hydrochloride in rats, dogs and monkeys. Xenobiotic Metabolism and Disposition, 5, 111–119.
   Google Scholar
• KUROIWA, S., INOTSUME, N. and NAKANO, M., 1986, Reduction of a calcium antagonist nicardipine by gastrointestinal bacteria. Y akugaku Zasshi, 106, 698–702.
   PubMedGoogle Scholar
• MAST, V., FISHER, G., Mixus, G. and EICHELBAU M., 1992, Use of pseudoracemate nitrendipine to elucidate the metabolic steps responsible for stereoselective disposition of nitrendipine enan-tiomers. British Journal of Clinical Pharmacology 33, 51–59.
   PubMedGoogle Scholar
• MUTO, K., KURODA, T., KAWATO, H., KARASAWA, A., KUBO, K. and NAKAMIZO, N., 1988a, Synthesis and pharmacological activity of stereoisomers of 1,4-dihydro-2,6-dimethy1-4(3-nitropheny1)-3,5 -pyridine-dic arb oxylic acid methyl-1 -(p henylmethyl)-3 -piperidinyl ester. Arzneimittel-Forschung/Drug Research, 38, 1662–1665.
   PubMed Web of Science ®Google Scholar
• MUTO, K., KURODA, T., KAWATO, H., NISHIKAWA, H. and NAKAMIZO, N., 1988b, Synthesis of expected metabolites of benidipine hydrochloride. Arzneimittel-Forschung /Drug Research, 38, 1666–1670.
   PubMedGoogle Scholar
• NIWA, T., TOKUMA Y NAKAGAWA, K., NOGUCHI, H., YAMAZOE, Y. and KATO, R., 1988, Stereoselective oxidation and plasma protein binding of nilvadipine, a new dihydropyridine calcium antagonist, in man. Res. Communications in Chemistry, Pathology and Pharmacology, 60, 162–167.
   Google Scholar
• NIWA, T., TOKUMA, Y., NAKAGAWA, K. and HIGUCHI, H., 1989, Stereoselective oxidation of nilvadipine, a new dihydropyridine calcium antagonist, in rat and dog liver. Drug Metabolism and Disposition, 17, 64–68.
   PubMed Web of Science ®Google Scholar
• NODA, H., FroD, Y. and FUJITA, T., 1990, The antihypertensive effect and benidipine hydrochloride in patients with essential hypertension. Japanese Pharmacology and Therapeutics, 18 (suppl. 14), 21–30.
   Google Scholar
• SOON, P. A. and BREIMER, D. D., 1991, Stereoselective pharmacokinetics of oral and intravenous nitrendipine in healthy male subjects. British Journal of Clinical Pharmacology, 32, 11-16. SooN, P. A., MULDERS, T. M., UCHIDA, E., SCHOEMAICER, H., COHEN, A. F. and BREMER, D. D., 1993, Stereoselective pharmacokinetics of oral felodipine and nitrendipine in healthy subjects: correlation with nifedipine pharmacokinetics. European Journal of Clinical Pharmacology, 44, 163–169.
   Google Scholar
• TAKAYAMA, F., IWASAWA, Y., SAITO, K., SHIRATORI, K. and OHTAWA, M., 1989, Metabolism of a new dihydropyridine calcium antagonist in rats and dogs. Xenobiotica, 19, 1407–1420.
   PubMed Web of Science ®Google Scholar
• TAKAYAMA, F., SAITO, K., Ism, Y., SHIRATORI, K. and OHTAWA, M., 1991, Sex difference in the stereoselective metabolism of a new dihydropyridine calcium channel blocker, in rat studies in vivo and in vitro. Xenobiotica, 21, 557–568.
   PubMed Web of Science ®Google Scholar
• TERASHITA, S., SAWAMOTO, T., DEGUCHI, S., TOKUMA, Y. and HATA, T., 1995, Sex-dependent and independent renal excretion of nilvadipine metabolites in rat: evidence for a sex-dependent active secretion in kidney. Xenobiotica, 25, 37–47.
   PubMed Web of Science ®Google Scholar
• TOKUMA, Y., FUJIWARA, T. and NOGUCHI, H., 1987, Determination of (+)- and (— )-nilvadipine in human plasma using chiral stationary-phase liquid chromatography-mass spectrometry, and a preliminary pharmacokinetic study in humans. Journal of Pharmaceutical Science, 76, 310-313. TOKUMA, Y., FUJIWARA, T., NIWA, T., HASHIMOTO, T. and NOGUCHI, H., 1989, Stereoselective disposition of nilvadipine a new dihydropyridine calcium antagonist, in the rat and dog. Research Communications in Chemistry, Pathology and Pharmacology, 63, 249–262.
   Google Scholar
• TOWART, R., WEHINGER, E., MEYER, H. and KAZDA, S., 1982, The effects of nimodipine, its optical isomers and metabolites on isolated vascular smooth muscle. Arzneimittel-Forschung /Drug Research, 32, 338–346.
   PubMed Web of Science ®Google Scholar
• WEIDOLF, L. and HOFFMANN, K.-J., 1984, Physico-chemical properties of urinary metabolites of felodipine, a new vasodilator drug. II. Lactone kinetics, acid dissociation and distribution constants of two hydroxycarboxylic metabolite. Acta Pharmaceutka Suecica, 21, 331–344.
   Google Scholar
• YAMADA, K., YASUI, S., HAYAKAWA, K., HIEZIMA, K. MURAKAMI, E., TAKEKOSHI, Y., YAMAZAKI, N., HIRAKAWA, S., ITOH, Y., TOYAMA, J., TOBATA, I., OGAWA, K., MIZUNO, Y., WATANABE, T., TAKEZAWA, H., NAKANO, T., TOYAMA, S. and NAKAJIMA, M., 1990, Clinical evaluation of benidipine hydrochloride (KW-3049) in angina pectoris—dose finding study by double blind method. Japanese Pharmacology and Therapeutics, 18, (suppl. 14), 191–210.
   Google Scholar
• YAMAGUCHI, M., YAMASHITA, K., AOKI, I., TABATA, T., HIRAI, S. and YASHIKI, T., 1992, Determination of manidipine enantiomers in human serum using chiral chromatography and column-switching liquid chromatography. Journal of Chromatography, 575, 123–129.
   PubMed Web of Science ®Google Scholar
• YOSHINAGA, K., IimuRA, K., ABE, K., ISHII, T., SARUTA, T., KANEKO, Y., IT0H, K., MASUYAMA, Y., KOKUHU, T. and ARAKAWA, K., 1990a, Clinical efficacy of benidipine hydrochloride (KW-3049) in essential hypertension (Early Phase II Study). Japanese Pharmacology and Therapeutics, 18 (suppl. 14), 49–58.
   Google Scholar
• YOSHINAGA, K., IimuRA, K., ABE, K., ISHII, T., SARUTA, T., KANEKO, Y., IT0H, K., MASUYAMA, Y., KoKuHu, T., ARAKAWA, K. and SH1MIDZU, N., 1990b, A study of benidipine hydrochloride (KW-3049) on the antihypertensive effects and safety in essential hypertensive patients in long-term treatment. Japanese Pharmacology and Therapeutics, 18 (suppl. 14), 81–102.
   Google Scholar